Walgreens to pay $270 million for overbilling prescription drugs, insulin pens

With all of the attention currently placed on prescription drug prices, it’s difficult to believe that a major retail distributor of medications would do anything but toe the proverbial line when it comes to sales practices. However, last month, Walgreens was ordered to pay more than $270 million for improperly billing Medicare, Medicaid and other state- and federal-level programs over the course of 10 years.
The suit is broken down into two components. In one part, the company has been ordered to pay $209.2 million for improper billing practices surrounding the dispensation of hundreds

Source link

Related posts

Barrett's Tied to Better Survival in Esophageal Ca


What are the Major Causes of Abdominal Pain?


Video of the Week: Dr. Francis Farraye on IBD: The First Visit


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy